Skip to main content
SpringerLink
Log in

Bevacizumab

First report of splenic infarction: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Malka D, van den Eynde M, Boige V, Dromain C, Ducreux M.Splenic infarction and bevacizumab. Lancet Oncology 7: 1038, No. 12, Dec 2006 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab. React. Wkly. 1135, 10 (2007). https://doi.org/10.2165/00128415-200711350-00036

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711350-00036

Keywords

Search

Navigation